Uptake of evidence-based statin therapy among atrial fibrillation patients in China: a report from the CAFR (Chinese Atrial Fibrillation Registry) Study

Shi-jun Xia, Xin Du, Chao Li, Jia-hui Wu, Ri-bo Tang, San-shuai Chang, Xue-yuan Guo, Rong-hui Yu, De-yong Long, Rong Bai, Nian Liu, Cai-hua Sang, Song-nan Li, Xiao-hui Liu, Jian-hong Pan, Jian-zeng Dong, Gregory Y.h. Lip, Chang-sheng Ma

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
188 Downloads (Pure)

Abstract

Background:

Atrial fibrillation (AF) is associated with increased incidence of cardiovascular disease, and hence, statin therapy is indicated in majority of AF patients.

Methods and results:

We analyzed data from the Chinese Atrial Fibrillation Registry (CAFR) involving 11,496 AF patients from 2011 to 2014. Practice patterns of statin therapy and factors associated with statin underuse were analyzed.

Based on the 2013 ACC/AHA cholesterol management guidelines, statins should be recommended for 67.4% (7720/11,461) of AF participants in CAFR, but only 43.4% (3352/7720) with appropriate indications were taking statins. Statin underuse in AF patients was independently associated with male sex, tertiary hospital treatment, outpatient attendance, and absence of ‘high risk’ cardiovascular risk factors (overweight, diabetes, coronary heart disease, stroke/transient ischemic attack/peripheral embolism and hypertension).

Conclusions:

A high proportion of Chinese AF patients had indications for statin therapy. Evidence-based statin prescribing was suboptimal in this population. Greater efforts should be made to improve a holistic approach to cardiovascular risk management in the Chinese AF population.
Original languageEnglish
Pages (from-to)284-289
JournalInternational Journal of Cardiology
Volume220
Early online date23 Jun 2016
DOIs
Publication statusPublished - 1 Oct 2016

Keywords

  • Atrial fibrillation
  • Evidence-based statin therapy
  • China

Fingerprint

Dive into the research topics of 'Uptake of evidence-based statin therapy among atrial fibrillation patients in China: a report from the CAFR (Chinese Atrial Fibrillation Registry) Study'. Together they form a unique fingerprint.

Cite this